Literature DB >> 20141569

Copper binding regulates intracellular alpha-synuclein localisation, aggregation and toxicity.

Xiaoyan Wang1, Dima Moualla, Josephine A Wright, David R Brown.   

Abstract

Alpha-synuclein is a natively unfolded protein that aggregates and forms inclusions that are associated with a range of diseases that include Parkinson's Disease and Dementia with Lewy Bodies. The mechanism behind the formation of these inclusions and their possible role in disease remains unclear. Alpha-synuclein has also been shown to bind metals including copper and iron. We used a cell culture model of alpha-synuclein aggregation to examine the relationship between metals and formation of aggregates of the protein. While the levels of iron appear to have no role in aggregate formation or localisation of the protein in cells, copper appears to be important for both aggregation and cellular localisation of alpha-synuclein. Reduction in cellular copper resulted in a great decrease in aggregate formation both in terms of large aggregates visible in cells and oligomers observed in western blot analysis of cell extracts. Reduction in copper also resulted in a change in localisation of the protein which became more intensely localised to the plasma membrane in medium with low copper. These changes were reversed when copper was restored to the cells. Mutants of the copper binding domains altered the response to copper. Deletion of either the N- or C-termini resulted in a loss of aggregation while deletion of the C-termini also resulted in a loss of membrane association. Increased expression of alpha-synuclein also increased cell sensitivity to the toxicity of copper. These results suggest that the potential pathological role of alpha-synuclein aggregates is dependent upon the copper binding capacity of the protein.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20141569     DOI: 10.1111/j.1471-4159.2010.06638.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  27 in total

1.  Divalent metal ions enhance DOPAL-induced oligomerization of alpha-synuclein.

Authors:  Yunden Jinsmaa; Patricia Sullivan; Daniel Gross; Adele Cooney; Yehonatan Sharabi; David S Goldstein
Journal:  Neurosci Lett       Date:  2014-03-23       Impact factor: 3.046

Review 2.  Coherent and Contradictory Facts, Feats and Fictions Associated with Metal Accumulation in Parkinson's Disease: Epicenter or Outcome, Yet a Demigod Question.

Authors:  Mohd Sami Ur Rasheed; Sonam Tripathi; Saumya Mishra; Mahendra Pratap Singh
Journal:  Mol Neurobiol       Date:  2016-08-01       Impact factor: 5.590

Review 3.  Antioxidant gene therapy against neuronal cell death.

Authors:  Juliana Navarro-Yepes; Laura Zavala-Flores; Annadurai Anandhan; Fang Wang; Maciej Skotak; Namas Chandra; Ming Li; Aglaia Pappa; Daniel Martinez-Fong; Luz Maria Del Razo; Betzabet Quintanilla-Vega; Rodrigo Franco
Journal:  Pharmacol Ther       Date:  2013-12-12       Impact factor: 12.310

Review 4.  Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications.

Authors:  D Allan Butterfield; Marzia Perluigi; Tanea Reed; Tasneem Muharib; Christopher P Hughes; Renã A S Robinson; Rukhsana Sultana
Journal:  Antioxid Redox Signal       Date:  2012-01-18       Impact factor: 8.401

5.  Environmental and genetic factors support the dissociation between α-synuclein aggregation and toxicity.

Authors:  Anna Villar-Piqué; Tomás Lopes da Fonseca; Ricardo Sant'Anna; Éva Mónika Szegö; Luis Fonseca-Ornelas; Raquel Pinho; Anita Carija; Ellen Gerhardt; Caterina Masaracchia; Enrique Abad Gonzalez; Giulia Rossetti; Paolo Carloni; Claudio O Fernández; Debora Foguel; Ira Milosevic; Markus Zweckstetter; Salvador Ventura; Tiago Fleming Outeiro
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-05       Impact factor: 11.205

6.  Copper(II) enhances membrane-bound α-synuclein helix formation.

Authors:  Heather R Lucas; Jennifer C Lee
Journal:  Metallomics       Date:  2011-02-03       Impact factor: 4.526

7.  N-terminal deletion does not affect α-synuclein membrane binding, self-association and toxicity in human neuroblastoma cells, unlike yeast.

Authors:  Katherina Vamvaca; Peter T Lansbury; Leonidas Stefanis
Journal:  J Neurochem       Date:  2011-09-20       Impact factor: 5.372

8.  Role of neurotoxicants and traumatic brain injury in α-synuclein protein misfolding and aggregation.

Authors:  Dharmin Rokad; Shivani Ghaisas; Dilshan S Harischandra; Huajun Jin; Vellareddy Anantharam; Arthi Kanthasamy; Anumantha G Kanthasamy
Journal:  Brain Res Bull       Date:  2016-12-16       Impact factor: 4.077

9.  Overexpression of alpha-synuclein at non-toxic levels increases dopaminergic cell death induced by copper exposure via modulation of protein degradation pathways.

Authors:  Annadurai Anandhan; Humberto Rodriguez-Rocha; Iryna Bohovych; Amy M Griggs; Laura Zavala-Flores; Elsa M Reyes-Reyes; Javier Seravalli; Lia A Stanciu; Jaekwon Lee; Jean-Christophe Rochet; Oleh Khalimonchuk; Rodrigo Franco
Journal:  Neurobiol Dis       Date:  2014-12-08       Impact factor: 5.996

Review 10.  Catecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disorders.

Authors:  David S Goldstein; Irwin J Kopin; Yehonatan Sharabi
Journal:  Pharmacol Ther       Date:  2014-06-16       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.